Bristol-Myers Squibb Co.

Links: Y! CELG MM R&D deep dive BMY Roulette CELG legacy IV board (still active) CELG legacy IV board (premium) BMY Roulette 2020

BMY / Message Board

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
1773	Re: Is Gio Right About BMY Share Repurchases At This Level?	GN	tocentsworth		1	2/20/2020 5:47:37 PM

1772	Celg CVRs	GN	hopesprings_us		1	2/20/2020 5:41:06 PM

1771	Re: Is Gio Right About BMY Share Repurchases At This Level?	GN	Doolen		4	2/20/2020 1:55:24 PM

1770	Is Gio Right About BMY Share Repurchases At This Level?	GN	tocentsworth		0	2/20/2020 12:33:06 PM

1769	Yet another combo Optivo study	GN	cptspr		4	2/20/2020 11:32:04 AM

1768	Compugen Announces Phase 1/2 Triple Combination Study to Evaluate COM701 in Combination with Bristol-Myers Squibb’s Opdivo® (Nivolumab) and TIGIT Inhibitor	GN	JBWIN		3	2/20/2020 10:25:44 AM

1767	Building IP: Juno Therapeutics Patent APplication re "IMMUNOTHERAPY METHODS AND COMPOSITIONS INVOLVING TRYPTOPHAN METABOLIC PATHWAY MODULATORS"	GN	JBWIN		0	2/20/2020 12:22:21 AM

1766	Multiple Sclerosis Research Australia (MSRA) 3Feb2020 Article "Three MS Treatments up for Consideration for PBS Inclusion" (one of which is ZEPOSIA/Ozanimod in RRMS)	GN	JBWIN		9	2/19/2020 3:34:22 PM

1765	Re: Investor day	GN	Doolen		8	2/19/2020 12:48:02 PM

1764	Investor day	GN	cptspr		10	2/19/2020 10:00:39 AM


	About Us • Contact Us • Follow Us on Twitter • Members Directory • Help Center • Advertise Not a member yet? What are you waiting for? Create Account Want to contribute? Support InvestorVillage by donating © 2003-2019 Investorvillage.com. All rights reserved. User Agreement